Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
Pelthos Therapeutics (NYSE American: PTHS), a biopharmaceutical company, announced its participation in the upcoming Wells Fargo Healthcare Conference. CEO Scott Plesha and CFO Frank Knuettel will deliver a presentation on Wednesday, September 3rd, 2025 at 1:30 p.m. ET.
The presentation will be accessible via webcast on the Events and Presentations section of Pelthos' website, with replays available for 90 days following the event. Institutional investors interested in one-on-one meetings should contact their sales representatives.
Pelthos Therapeutics (NYSE American: PTHS), azienda biofarmaceutica, ha annunciato la propria partecipazione alla prossima Wells Fargo Healthcare Conference. Il CEO Scott Plesha e il CFO Frank Knuettel terranno una presentazione mercoledì 3 settembre 2025 alle 13:30 ET.
La presentazione sarà trasmessa in webcast nella sezione Eventi e Presentazioni del sito di Pelthos; le repliche saranno disponibili per 90 giorni dopo l'evento. Gli investitori istituzionali interessati a incontri one-to-one sono invitati a contattare i propri rappresentanti di vendita.
Pelthos Therapeutics (NYSE American: PTHS), compañía biofarmacéutica, anunció su participación en la próxima Wells Fargo Healthcare Conference. El CEO Scott Plesha y el CFO Frank Knuettel ofrecerán una presentación el miércoles 3 de septiembre de 2025 a la 1:30 p.m. ET.
La presentación se podrá ver por webcast en la sección Eventos y Presentaciones del sitio web de Pelthos; las repeticiones estarán disponibles durante 90 días tras el evento. Los inversores institucionales que deseen reuniones individuales deben contactar a sus representantes de ventas.
Pelthos Therapeutics (NYSE American: PTHS)는 바이오제약 회사로서 다가오는 Wells Fargo Healthcare Conference에 참석한다고 발표했습니다. CEO 스콧 플레샤(Scott Plesha)와 CFO 프랭크 크뉘텔(Frank Knuettel)이 2025년 9월 3일 수요일 동부시간 오후 1시 30분에 발표를 진행합니다.
발표는 Pelthos 웹사이트의 이벤트 및 프레젠테이션 섹션에서 웹캐스트로 시청할 수 있으며, 행사 후 90일 동안 다시보기로 이용 가능합니다. 1대1 미팅을 원하시는 기관투자가는 영업 담당자에게 문의하시기 바랍니다.
Pelthos Therapeutics (NYSE American: PTHS), société biopharmaceutique, a annoncé sa participation à la prochaine Wells Fargo Healthcare Conference. Le CEO Scott Plesha et le CFO Frank Knuettel présenteront le mercredi 3 septembre 2025 à 13h30 ET.
La présentation sera diffusée en webcast dans la rubrique Événements et Présentations du site de Pelthos ; les rediffusions seront disponibles pendant 90 jours après l'événement. Les investisseurs institutionnels souhaitant des réunions individuelles doivent contacter leurs représentants commerciaux.
Pelthos Therapeutics (NYSE American: PTHS), ein biopharmazeutisches Unternehmen, hat seine Teilnahme an der bevorstehenden Wells Fargo Healthcare Conference angekündigt. CEO Scott Plesha und CFO Frank Knuettel werden am Mittwoch, 3. September 2025 um 13:30 Uhr ET eine Präsentation halten.
Die Präsentation ist als Webcast in der Rubrik Veranstaltungen und Präsentationen auf der Pelthos-Website verfügbar; Wiederholungen stehen für 90 Tage nach der Veranstaltung zur Verfügung. Institutionelle Investoren, die Einzelgespräche wünschen, sollten ihre Vertriebsvertreter kontaktieren.
- None.
- None.
Management’s presentation will take place on Wednesday, September 3rd, 2025 at 1:30 pm (ET)
DURHAM, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel, CFO, will participate in the Wells Fargo Healthcare Conference. Management’s presentation will take place on Wednesday, September 3rd, 2025 at 1:30 p.m. E.T.
For one-on-one meeting requests please contact your institutional sales representative. A webcast of the presentation will be available on the Events and Presentations pages of Pelthos’ website at https://pelthos.com. Archived replays will be available for 90 days following the event.
About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The company’s lead product ZELSUVMI™ (berdazimer) topical gel,
Contacts
Pelthos Investor Inquiries:
Mike Moyer
Managing Director, LifeSci Advisors, LLC
mmoyer@lifesciadvisors.com
Media:
KWM Communications
Kellie Walsh / Rachel Kessler
pelthos@kwmcommunications.com
(914) 315-6072
FAQ
When is Pelthos Therapeutics (PTHS) presenting at the Wells Fargo Healthcare Conference 2025?
Who will represent Pelthos Therapeutics at the Wells Fargo Healthcare Conference?
How can investors access Pelthos Therapeutics' Wells Fargo conference presentation?
How can investors schedule one-on-one meetings with Pelthos Therapeutics management?
